Introduction
The spontaneously hypertensive rat (SHR) is a laboratory model of naturally developing hypertension and heart failure that appears to be similar in many aspects to essential hypertension in humans (Trippodo & Frohlich, 1981) . Systolic blood pressure in SHR rapidly increases during 5 to 10 weeks of age and develops cardiac hypertrophy between 9 and 12 weeks of age (Shimamoto et al., 1982) . Increasing evidence from different experimental models supports the concept that oxidative stress contributes to the pathogenesis of myocardial hypertrophy and in the process of myocardial remodeling leading to heart failure (Yücel et al., 1998; Lasségue & Griendling, 2004) .
The oxidative stress is the result of an increase of reactive oxygen species (ROS) and/or inadequate antioxidant defense mechanisms. It has been shown that an increase in the activity and expression of myocardial NAD(P)H oxidase (NOX) is the main source of ROS in cardiac hypertrophy (Bendall et al., 2002; Griendling et al., 2000; Xiao et al et al., 2002) . However, existing data about the antioxidant status in hypertension are inconsistent. Some studies have shown that the activities of one or more antioxidant enzymes are lower (Ito et al, 1995; Newaz & Nawal, 1999) , higher (Czonka et al., 2000) or without changes (Gómez-Amores et al., 2006; Girard et al, 2005) compared with normotensive controls. Although the underlying causes of these discrepancies are unknown, it may be possibly due to the use of different hypertension models, animals at different hypertensive stages and/or different experimental preparations.
Methods
Experiments were conducted with 40 days and 4-, 11-and 19-month-old male SHR and agematched Wistar rats. All animals were identically housed under controlled lighting (12 hs) and temperature (20 °C) conditions with free access to standard rat chow and tap water. The experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised in 1996) . Systolic blood pressure (SBP) was recorded by the tail-cuff method (Camilión de Hurtado et al., 2002) . Left ventricular hypertrophy (LVH) was evaluated by the ratio between heart weight (HW) and tibia length (TL) as previously described (Yin et al., 1982) . Wistar strain was used as normotensive control rat. For the biochemical determinations SHR and Wistar rats of 4-and 19 months-old were used. The animals were decapitated and hearts were quickly removed and perfused with ice-cold saline solution (0.9% NaCl) to remove the blood. Left ventricle (LV) samples were taken to assay NOX activity, superoxide production and protein nitration. The rest of the heart was homogenized in 5 volume of 25 mM PO 4 KH 2 -140 mM ClK at pH = 7.4 containing protease inhibitors cocktail (Complete Mini Roche) with a Polytron homogenizer. An aliquot of heart homogenate was used to assess lipid peroxidation. The remaining homogenate was centrifuged at 12000 x g for 5 min at 4º C and the supernatant stored at -70 ºC until superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) activities were assayed. Protein concentration was evaluated by Bradford method (Bradford, 1976) using bovine serum albumin as a standard.
Assessment of lipid peroxidation
Lipid peroxidation was determined by measuring the level of thiobarbituric acid reactive substances (TBARS), expressed as nmol/mg protein. Heart homogenates were centrifuged at 2000 x g for 10 min. Supernatants (0.5 ml) were mixed with 1.5 ml trichloroacetic acid (30 % w/v), 1 ml thiobarbituric acid (0.7% w/v) and 0.5 ml water followed by boiling during 15 min. After cooling, absorbance was determined spectrophotometrically at 535 nm, using a ε value of 1.56 x 10 5 M -1 cm −1 (Buege & Aust, 1978) .
Assessment of protein nitration
The interaction of peroxynitrite leads to nitrotyrosine formation actually considered as an indirect marker of oxidative /nitrosative stress (Halliwell, 1997) . Thus, we assessed nitrotyrosine level by Western blot analysis. A sample of left ventricle was homogenized in lysis buffer (300 mM sucrose; 1 mM DTT; 4 mM EGTA, protease inhibitors cocktail: 1 tablet/15 ml of buffer; 20 mM Tris-HCl, pH 7.4). After a brief centrifugation proteins were www.intechopen.com
Oxidative Damage in Cardiac Tissue from Normotensive and Spontaneously Hypertensive Rats: Effect of Ageing 143 denatured and equal amounts of protein subjected to PAGE and electrotransferred to PVDF membranes. Membranes were incubated with an anti-nitrotyrosine polyclonal antibody (Cayman Chemical). A peroxidase-conjugated, anti-rabbit IgG (Santa Cruz Biotechnology) was used as secondary antibody, and finally bands were visualized with ECL-Plus chemiluminescence detection system (Amersham). Autoradiograms were analyzed by densitometric analysis (Scion Image).
Determination of NAD(P)H oxidase (NOX) activity
Left ventricular slices (LVS, 1 x 5 mm, 3 -3.5 mg dry weight) were incubated for 5 min at 37 °C in Krebs-Hepes buffer (in mmol/l: 99 ClNa, 4.69 ClK, 1.87 Cl 2 Ca, 1.2 SO 4 Mg, 1.03 K 2 PO 4 , 25 CO 3 HNa, 20 Hepes, 11.1 glucose) bubbled with 95% O 2 -5% CO 2 to maintain pH 7.4 and then transferred to glass scintillation vials containing the same buffer with 5 M lucigenin. Chemiluminiscence was assessed at 37°C over 15 minutes in a Scintillation counter (Packard 1900 TR) at 1-minute intervals. Vials containing all components without tissue were previously counted and the values were substracted from the chemiluminiscence signals obtained in the presence of LVS. NOX activity was measured in the presence of 100 mM NAD(P)H and expressed as cpm/mg dry weight of LVS (Souza et al., 2002) .
Measurement of superoxide (O 2 -. ) production
Superoxide production was measured in LVS with lucigenin-enhanced chemiluminiscence in Krebs-Hepes buffer with 5 M lucigenin (Khan et al., 2004) . The chemiluminiscence in arbitrary units (AU) was recorded with a luminometer (Chameleon, Hidex) during 30 seconds each with 4.5 min interval during 30 minutes. O 2 -. production was expressed as AU per mg dry weight per minute. To determine the involvement of NOX in O 2 -. production, the slices were pretreated during 30 min with 300 M apocynin.
SOD, CAT and GPx activities assays
SOD activity was determined by inhibition of formazan production (produced by nitroblue tetrazolium (NBT) reduction by superoxide anion) at pH 10.2 and 25º C. The reaction mixture consists in: 100 M xanthine, 100 M EDTA, 25 M NBT, 50 mM CO 3 Na 2 , pH 10.2. The reaction was started by the addition of xanthine oxidase, reading the absorbance at 560 nm each 30 sec for 5 min (Beauchamp & Fridovich, 1971) . One unit of SOD assay was defined as the amount of enzymatic protein required to inhibit 50 % of NBT reduction.
CAT activity was determined by the procedure of Aebi (1984) . Decrease in absorbance at 240 nm by the addition of 30 mM H 2 O 2 was monitored each 15 sec and for 30 sec. One unit of CAT assay was defined as the amount of the enzyme that decomposed 1 mol of H 2 O 2 .
The GPx activity was measured according to Lawrence and Burk method (1976) . The assay reaction comprised 50 mM K 2 HPO 4 buffer, 1 mM EDTA, 1 mM NaN 3 , 1 mM reduced glutathione, 0.2 mM NADPH, 0.25 mM H 2 O 2 and 1 U/ml glutathione reductase. Gpx activity was assayed by following NADPH oxidation at 340 nm, measuring the absorbance each 15 sec for 5 min. The activity was calculated using a molar extinction coefficient for NADPH of 6.22 10 3 M −1 x cm −1 at 340 nm. One unit of the enzyme was represented the decrease of 1 mol of NADPH/min under assay conditions.
Statistical analysis
Data are presented as mean ± SE. Differences between Wistar and SHR, young and old groups were analyzed using two-way analysis of variance (ANOVA) with the NewmanKeul's post-hoc test used for multiple comparisons among groups, considering P < 0.05 as statistically significant.
Results
Comparing to age-matched W rats, SBP of SHR was higher at all ages examined. The analysis of the time course of SBP showed that as early as at 40-day-old the SHR exhibited higher SBP values compared to age-matched W rats. At 4-month-old SBP increased more in comparison to the youngest rats and it remained elevated throughout the last stage studied. LVH significantly increased in SHR at 4, 11 and 19-month-old compared to age-matched W rats. Higher values were obtained at 11 and 19-month-old SHR when compared to younger SHR. An increase in LVH was also observed in W rats with aging (11 and 19-month-old) compared to younger rats (Table 1) . Although there were no significant differences in NOX between SHR and Wistar hearts from young animals, an increase in aged rats (approximately 30% for Wistar and 60% for SHR) was obtained showing SHR the highest values (Fig. 3 ).
SHR
Similar O 2 -. production was obtained in hearts from Wistar rats and SHR at 4 months of age, whereas in older animals SHR showed a significantly higher O 2 -. production (approximately 170%) in comparison with age matched Wistar rats (approximately 70%) (Fig. 4) www.intechopen.com
Oxidative Damage in Cardiac Tissue from Normotensive and Spontaneously Hypertensive Rats: Effect of Ageing 147 the difference was not statistically significant. This may have been because the lucigenin method was unable to detect very small differences in O 2 -. levels that were only slightly above the background levels (Dikalov et al., 2007) . The activities of antioxidant enzymes are shown in Fig. 5, 6 and 7. SOD activity significantly decreased in older hearts from SHR (approximately 17 %) while not significant differences were detected in Wistar rats with aging (Fig. 5) .
Hearts from 4-month-old SHR exhibited a higher catalase activity (approximately 40%) in comparison to hearts from age-matched Wistar rats and it decreased in 19-month-old SHR. In Wistar rats CAT activity did not change with aging (Fig. 6 ).
Compared to younger animals, a significant decrease of GPx activity was detected in hearts from 19-month-old SHR and Wistar rats. No differences were detected between SHR and age-matched Wistar rats (Fig. 7) . 
Discussion
The present study shows an increase of oxidative stress associated to ageing in both rat strains, showing SHR the highest values. Oxidative stress is a major contributor to the aging process (Fukagawa, 1999) and appears to be a common feature of hypertensive disorders from diverse origins (Ito et al., 1995; Dobrian et al., 2003; Vaziri & Sica, 2004; Swei et al., 1997) . The damage caused by oxidative stress during aging becomes more evident when analyzing the effect of ROS on organic macromolecules, like proteins and lipids. Lipid peroxidation is a major contributor to the age-related loss of membrane fluidity, especially related to increase in the levels of two aldehydic lipid peroxidation products, malonyldialdehyde (MDA) and 4-hydroxy-2-nonenal (HNE). Therefore, it is not surprising that lipid peroxidation is increased in the aged heart as demonstrated by higher levels of MDA (Cocco et al., 2005) or HNE (Judge et al., 2005) . However, in the present study, in accordance with previously reported data (Muscari et al., 1990; Navarro-Arévalo et al., 1999; Cand & verdetti, 1989 ), we did not find any increase of TBARS in hearts from normotensive rats with aging. These results can be explained considering that the normal hearts have a reduced amount of substrate for the lipoperoxidation (Cand & Verdetti, 1989) or /and the end products of lipoperoxidation are readily metabolized (Muscari et al., 1990) or possess efficient antioxidant defence system . However, we detected an increase in TBARS content with aging in hearts from SHR, compared to age-matched Wistar rats. Moreover, 19-monthold SHR exhibited the highest hypertrophy index and level of lipid peroxidation suggesting that an increase of oxidative damage can be the consequence or the reason for the persistent elevated systolic blood pressure and/or increased cardiac hypertrophy in addition to aging.
Nitric oxide (NO) plays pivotal roles in the maintenance of blood pressure and vascular tone (Loscalzo & Welch, 1995) . Superoxide avidly reacts with NO and in the process produces highly reactive and cytotoxic products, like peroxynitrite (ONOO-). Peroxynitrite, in turn, reacts with and modifies various molecules, namely lipids, DNA, and proteins. For instance, peroxynitrite reacts with the tyrosine and cysteine residues in protein molecules to produce nitrotyrosine and nitrocysteine, leading to inactivation of important antioxidant enzymes, like SOD (Mac Millan-Crow & Cruthirds, 2001; Alvarez et al., 2004) . In addition to these and other harmful biochemical reactions, the oxidation of NO by ROS inevitably results in functional NO deficiency, which can contribute to pathogenesis and maintenance of hypertension and its long-term consequences. In agreement with previous findings in the vasculature of hypertensive animals (Mc Intyre et al., 1999; Zalba et al., 2001 ), we detected a higher O 2 -. production in cardiac tissue of aged SHR compared to age-matched normotensive Wistar rats. The fact that blood pressure of SHR decreased with antioxidant therapy implies that oxidative stress is involved in the genesis and/or maintenance of hypertension (Vaziri et al., 2000) . Recent investigations using hypertensive models other than SHR have shown that an increase of cellular tolerance to oxidative stress is one of the mechanisms responsible for the efficacy of anti hypertensive treatments such as calcium antagonists (Umemoto et al., 2004; Hirooka et al., 2006) , angiotensin II type 1 receptor antagonists, or angiotensin-converting enzyme inhibitors (Takai et al., 2005; Tanaka et al., 2005) . In our study, hearts from 4-month-old SHR and Wistar rats showed a similar nitrotyrosine content. In addition to lipid peroxidation data, this result is another demonstration that the higher LVH observed in young SHR relative to age-matched Wistar rats was not accompanied by higher nitrosative damage. Aged Wistar rats exhibited an increase in nitrotyrosilation compared with young animals. This increase was lower in Wistar in comparison to SHR, indicating that the addition of hypertrophy to aging process leads to a high degree of nitration due to an increased imbalance in myocardial production of either NO or O 2 -. . Although we did not measure the expression or activity of NOS, it has been reported that aged hearts exhibited increased myocardial NOS-cGMP signaling associated with an up-regulation of NOS (Zieman et al., 2001; Llorens et al., 2005) . Therefore, higher levels of nitrotyrosine in aged SHR hearts would be attributed to an increase of peroxynitrite derived from an excessive production of both reactive species, NO and O 2 -. . Another possibility for explaining the higher oxidative and nitrosative stress of aged SHR compared to Wistar rats is a decrease in NO availability due to an increase in O 2 -. production.
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Mitochondria occupy a central position in the metabolism of ROS, supporting the so-called "free radical theory of aging" (Beckman & Ames, 1998; Hardman, 1956; Hardman, 1988) . Other cardiovascular sources of ROS include the enzymes xanthine oxidoreductase (Berry & Hare, 2004) , NOX (multisubunit membrane complexes) (Griedling et al., 2000) and eNOS uncoupling (Kuzkaya et al., 2003; Landmesser et al., 2003) . This eNOS transformation takes place when its essential cofactor (6R)-5,6,7,8-tetrahydro-L-biopterin (BH4) is oxidized by ONOO-then a functional NOS is converted into a dysfunctional O 2 -. generating enzyme that contributes to oxidative stress. Abnormal activation and expression of myocardial NOX have been suggested to be the mains sources of ROS in the hypertrophic and failing myocardium (Bendall et al., 2002; Li et al., 2002) . A recent paper of Miyagawa et al. (2007) shows that the production of O 2 -. by NOX in femoral arteries of SHR in comparison to WKY is enhanced, resulting in the inactivation of NO and impairment of endothelial modulations of vascular contractions. In our study, whereas young SHR showed a similar NOX activity as age-matched Wistar, an increase in the activity of this enzyme was detected in aged SHR, suggesting that NOX-dependent ROS production would be mediating both the hypertrophic response and aging. Apocynin is a well characterized inhibitor of NOX (Meyer & Schmitt, 2000) . It acts by impeding the assembly of the p47-phox and p67-phox subunits within the membrane NOX complex (Meyer & Schmitt, 2000; Hamilton et al., 2001) . Some of the effects of apocynin treatment are protection of the endothelium from the initiating events of atherosclerosis (Hamilton et al., 2001 ), a reduction of p22-phox mRNA expression and cardiac hypertrophy in aldosterone-infused rats (Park et al., 2004) , and a prevention of hyperglycemia-induced intracellular ROS elevation and myocyte dysfunction (Privratsky et al., 2003) . Aponycin has also been shown to reduce oxidative stress in stroke-prone spontaneously hypertensive rats, leading to the suppression of cardiac hypertrophy, inflammation and fibrosis (Yamamoto et al., 2006) . Under our experimental conditions, apocynin blunted the O 2 -. production in hearts from aged SHR and Wistar rats. Although a significant increase in NOX activity was only evident in aged SHR hearts, we suggest that NOX-dependent ROS production would mediate both the hypertrophic response and aging.
In the myocardium, as in other tissues, antioxidant enzymes protect cells by maintaining ROS at low levels, thus preventing oxidative damage to biological molecules. SOD rapidly converts O 2 -. to H 2 O 2 , which is further degraded by CAT and GPx. The levels of the antioxidant enzymes are sensitive to the oxidative stress and increased or decreased levels have been reported in different pathologies in which an enhancement of ROS is cause or consequence of the disease (Navarro-Arévalo et al., 1999; Ulker et al., 2003) . Our data show that SOD activity in hearts from young SHR was slightly but not significantly higher than Wistar rats. The lack of significant difference between SOD activities of hearts from both rat strains is in accordance with previous findings (Gómez-Amores et al., 2006; Wilson & Johnson, 2000; Robin et al., 2004) . GPx activity was slightly but no significantly higher in hearts from young SHR compared to age-matched Wistar rats whereas CAT activity showed a significant increase. An opposite result has been recently demonstrated in thoracic aorta of SHR in which a CAT activity decreased and a concomitant increase of H 2 O 2 were detected (Ulker et al., 2003) . Although we did not have experimental evidence, the increase in CAT activity without GPx one changes detected in young SHR would indicate that CAT is acting as compensatory mechanism. This action could lead to a diminution of H 2 O 2 amount in our preparations and could explain the similar TBARS and nitrotyrosine content obtained in young hearts from both rat strains. Aged Wistar rats did not exhibit any change in SOD and GPx activities. However, a significant diminution of antioxidant enzymes was evident in aged compared to younger SHR. These data are in concordance with those reported by Ito et al. (1995) and opposed to recent observations of Csonka et al. (2000) . In addition, both rat strains of 19 months old showed similar antioxidant enzyme activity. Therefore, this fact could not explain the differences of oxidative damage detected between aged SHR and W rats. These differences could be attributed to a significantly higher NOX activity in aged than young SHR in accordance with the increased O 2 -. production with aging, indicating that the compensatory mechanism detected in young rats will be abnormal in cardiac tissue from aged SHR. In this regard, it is worth noting a previous report that an increase of SOD pharmacology potency by lecithinization is able to protect endothelial cells against alterations induced by ROS (Igarashi et al., 1992) . Another explanation to the differences observed would be related to angiotensin II content, which appears involved in the genesis of oxidative stress in another tissue than heart in the SHR model (De Godoy & Rattan, 2006) . This hypothesis was supported by the recent experiments performed in vascular tissue of stroke-prone SHR (Takai et al., 2005; Tanaka et al., 2005) in which the inhibition of angiotensin receptor or angiotensin-converting enzyme system produced a reduction of ROS production. Our results are also consistent with investigations showing that cardioprotective treatments are mediated by a restoration or up-regulation of antioxidant enzyme (Umemoto et al., 2004; Tanaka et al., 2005) . Accumulating evidence has suggested that ROS are capable to activate directly intracellular cascades involved in the regulation of hypertrophic growth (Takano et al., 2003) . It has been reported that Rho family proteins, specially Rac1, play critical roles in mechanical stress-induced hypertrophy responses and are involved in ROS-mediated activation of MAP kinases (such as p38, ERK1/2) and activation of nuclear factor-B. Moreover, Rac 1 is essential for assembly of plasma membrane NOX (Griendling et al., 2000) . Thus, in our experimental conditions, sustained hemodynamic load in SHR would modulate the action of extracellular stimuli (such as angiotensin II, norepinephrine, tumor necrosis factor-, epidermal growth factor) on Rac1 activation leading to NOX activation. The increase in O 2 -. production by NOX would, in presence of a deficient endogenous antioxidant system, activate redox-sensitive kinase cascades and transcription factors. These actions would produce an induction of immediate early genes, reexpression of fetal genes, increased mRNA content and protein synthesis thus leading to the increase in myocyte cross-sectional area and fibrosis observed in aged SHR heart.
Conclusion
This study shows that an increase in O 2 -. production in NOX dependent way and consequently higher oxidative damage appears associated to the aging process and to the increase in cardiac hypertrophy detected in hearts of SHR compared to age-matched Wistar rats. Thus, oxidative stress would be the cause and/or consequence of hypertrophy development in the SHR model.
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